<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Int J Mol Sci</journal-id>
<journal-id journal-id-type="publisher-id">ijms</journal-id>
<journal-title-group>
<journal-title>International Journal of Molecular Sciences</journal-title>
</journal-title-group>
<issn pub-type="epub">1422-0067</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31454888</article-id>
<article-id pub-id-type="pmc">6747313</article-id>
<article-id pub-id-type="doi">10.3390/ijms20174160</article-id>
<article-id pub-id-type="publisher-id">ijms-20-04160</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Rett Syndrome and Other Neurodevelopmental Disorders Share Common Changes in Gut Microbial Community: A Descriptive Review</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1893-0455</contrib-id>
<name>
<surname>Borghi</surname>
<given-names>Elisa</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-20-04160">1</xref>
<xref ref-type="corresp" rid="c1-ijms-20-04160">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vignoli</surname>
<given-names>Aglaia</given-names>
</name>
<xref ref-type="aff" rid="af1-ijms-20-04160">1</xref>
<xref ref-type="aff" rid="af2-ijms-20-04160">2</xref>
<xref ref-type="corresp" rid="c1-ijms-20-04160">*</xref>
</contrib>
</contrib-group>
<aff id="af1-ijms-20-04160"><label>1</label>Department of Health Sciences, Università degli Studi di Milano, 20142 Milan, Italy</aff>
<aff id="af2-ijms-20-04160"><label>2</label>Child Neuropsychiatry Unit, ASST Santi Paolo Carlo Hospital, 20142 Milan, Italy</aff>
<author-notes>
<corresp id="c1-ijms-20-04160"><label>*</label>Correspondence: <email>elisa.borghi@unimi.it</email> (E.B.); <email>aglaia.vignoli@unimi.it</email> (A.V.); Tel.: +39-02-503-23287 (E.B.); +39-02-8184-4201 (A.V.)</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>26</day>
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<month>9</month>
<year>2019</year>
</pub-date>
<volume>20</volume>
<issue>17</issue>
<elocation-id>4160</elocation-id>
<history>
<date date-type="received">
<day>13</day>
<month>7</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>8</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 by the authors.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>In this narrative review, we summarize recent pieces of evidence of the role of microbiota alterations in Rett syndrome (RTT). Neurological problems are prominent features of the syndrome, but the pathogenic mechanisms modulating its severity are still poorly understood. Gut microbiota was recently demonstrated to be altered both in animal models and humans with different neurodevelopmental disorders and/or epilepsy. By investigating gut microbiota in RTT cohorts, a less rich microbial community was identified which was associated with alterations of fecal microbial short-chain fatty acids. These changes were positively correlated with severe clinical outcomes. Indeed, microbial metabolites can play a crucial role both locally and systemically, having dynamic effects on host metabolism and gene expression in many organs. Similar alterations were found in patients with autism and down syndrome as well, suggesting a potential common pathway of gut microbiota involvement in neurodevelopmental disorders.</p>
</abstract>
<kwd-group>
<kwd>neurodevelopment</kwd>
<kwd>Rett syndrome</kwd>
<kwd>autism spectrum disorder</kwd>
<kwd>gut microbiota</kwd>
<kwd>
<italic>Clostridium</italic>
</kwd>
<kwd>
<italic>Sutterella</italic>
</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-ijms-20-04160" sec-type="intro">
<title>1. Introduction</title>
<p>The commensal microbial community inhabiting the mammalian gastrointestinal tract, microbiota, has been demonstrated to exert important functions both prenatally and postnatally [<xref ref-type="bibr" rid="B1-ijms-20-04160">1</xref>]. Several studies on germ-free mice established that, at the local level, the presence of pioneering microorganisms triggers the correct development and maturation of the gut-associated lymphoid tissue. Indeed, in the absence of microbiota, animals fail to complete Peyer patches and mesenteric lymph nodes maturation and display longer and thinner villi with a reduced vascular network [<xref ref-type="bibr" rid="B2-ijms-20-04160">2</xref>]. This intuitive and intimate relationship between the gut and its microbiota during development also applies to distant districts, with the brain as the most counterintuitive and intriguing. Microbial-derived signals are crucial for the physiological brain development, promoting neurotrophins secretion [<xref ref-type="bibr" rid="B3-ijms-20-04160">3</xref>], microglia maturation [<xref ref-type="bibr" rid="B4-ijms-20-04160">4</xref>], blood-brain barrier functionality (by enhancing tight-junction expression) [<xref ref-type="bibr" rid="B5-ijms-20-04160">5</xref>], and correct myelination [<xref ref-type="bibr" rid="B6-ijms-20-04160">6</xref>]. Brain development is tremendously vulnerable to environmental factors, and events occurring in early phases might have long-term effects later in life [<xref ref-type="bibr" rid="B7-ijms-20-04160">7</xref>]. Beside the described role in early infancy, the microbiota-gut-brain axis was recently recognized to be a highly complex and tightly regulated bidirectional network. From top to bottom, it encompasses the central nervous system (CNS), the sympathetic and parasympathetic branches of the autonomic nervous system, the enteric nervous system, and the neuroendocrine and neuroimmune systems [<xref ref-type="bibr" rid="B8-ijms-20-04160">8</xref>]. This complex network is enriched by the gut microbial community exerting a bottom-up modulation by interacting mainly with the vagus nerve and the neuroendocrine and neuroimmune systems [<xref ref-type="bibr" rid="B9-ijms-20-04160">9</xref>].</p>
<p>In this review, we will focus on gut microbiota changes in Rett syndrome (RTT), the most prevalent neurodevelopmental disorder in females, whose pathogenic mechanisms are still poorly understood and whose genetic background cannot fully explain the phenotypic heterogeneity.</p>
</sec>
<sec id="sec2-ijms-20-04160">
<title>2. Gut Microbiome Alterations in Neurodevelopmental Disorders</title>
<p>Neurodevelopmental disorders (NDs) are chronic disorders that affect CNS function during the developmental period in the domains of motor skills, cognition, communication, and/or behavior. The diagnosis of NDs is primarily clinical, based on a constellation of behaviors/symptoms that are specified in the diagnostic and statistical manual of mental disorders (DSM) [<xref ref-type="bibr" rid="B10-ijms-20-04160">10</xref>]. The most common ND worldwide is autism spectrum disorder (ASD), for which several studies, conducted since 2000 in different geographical regions and by different teams, have estimated a median prevalence of 62/10,000 [<xref ref-type="bibr" rid="B11-ijms-20-04160">11</xref>].</p>
<p>ASD is an extremely heterogeneous neurodevelopmental disorder and its onset can vary. Some children show signs from early infancy, while others exhibit symptoms of regression around 18–24 months. Other specific features may be recognizable only at an older age. Clinically, ASD is characterized by stereotypical behaviors and a deficit in social interaction and communication [<xref ref-type="bibr" rid="B12-ijms-20-04160">12</xref>]. In addition to the neuropsychiatric features, children with ASD often experience gastrointestinal (GI) problems that are more frequent and more severe compared with children from the general population. Functional constipation is the most common issue [<xref ref-type="bibr" rid="B13-ijms-20-04160">13</xref>], followed by diarrhea/chronic diarrhea, abdominal pain or discomfort, bloating, gas or flatulence, soiling, incontinence or bedwetting, reflux or heartburn, nausea or vomiting, and pain or difficulties in bowel movement [<xref ref-type="bibr" rid="B14-ijms-20-04160">14</xref>]. Gastrointestinal symptoms strongly correlate with the severity of autism and with increased irritability, anxiety, and social withdrawal [<xref ref-type="bibr" rid="B15-ijms-20-04160">15</xref>,<xref ref-type="bibr" rid="B16-ijms-20-04160">16</xref>]. This evidence elicits researches focusing on the connection between ASD and the gut microbiota. Intriguingly, an altered composition of gut microbiome has been demonstrated in subjects with ASD [<xref ref-type="bibr" rid="B17-ijms-20-04160">17</xref>,<xref ref-type="bibr" rid="B18-ijms-20-04160">18</xref>,<xref ref-type="bibr" rid="B19-ijms-20-04160">19</xref>,<xref ref-type="bibr" rid="B20-ijms-20-04160">20</xref>], suggesting a possible link between dysbiosis (an aberrant shift in microbial ecology) and neurodevelopmental diseases. Despite differences in cohorts, study designs, and methodologies, a common microbial signature has been identified (reviewed by Ding et al. [<xref ref-type="bibr" rid="B21-ijms-20-04160">21</xref>] and by the recent systematic review by Liu et al. [<xref ref-type="bibr" rid="B22-ijms-20-04160">22</xref>]). ASD-related major changes involve an increase in the relative abundance of <italic>Clostridium</italic> spp. and <italic>Sutterella</italic> spp., <italic>Bacteroides</italic> spp. and <italic>Desulfovibrio</italic> spp. and a depletion in <italic>Bifidobacterium</italic> spp., <italic>Blautia</italic> spp., <italic>Prevotella</italic> spp., and <italic>Veillonella</italic> spp. [<xref ref-type="bibr" rid="B19-ijms-20-04160">19</xref>,<xref ref-type="bibr" rid="B23-ijms-20-04160">23</xref>,<xref ref-type="bibr" rid="B24-ijms-20-04160">24</xref>]. The <italic>Clostridium</italic> hypothesis, suggesting the involvement of toxigenic bacteria in the onset of the ASD regressive form, was first suggested by Ellen Bolte [<xref ref-type="bibr" rid="B25-ijms-20-04160">25</xref>] and later supported by other authors [<xref ref-type="bibr" rid="B26-ijms-20-04160">26</xref>,<xref ref-type="bibr" rid="B27-ijms-20-04160">27</xref>]. Indeed, clostridia are spore-forming and can exert a toxic activity by producing exotoxins, phenol, and p-cresol [<xref ref-type="bibr" rid="B27-ijms-20-04160">27</xref>,<xref ref-type="bibr" rid="B28-ijms-20-04160">28</xref>]. P-cresol has been postulated as a possible urinary biomarker in ASD and its concentration correlates with constipation (slow fecal transit) [<xref ref-type="bibr" rid="B29-ijms-20-04160">29</xref>]. Other microbial-derived metabolites have been linked to ASD in recent years, including propionate. Propionate is a short-chain fatty acid (SFCA) and one of the main products of microbial fermentation, together with acetate and butyrate. SCFAs are utilized by the host as an energy source and exert other physiological functions. SCFAs participate in glucose homeostasis, affect lipid metabolism, regulate the immune system and inflammatory response, and serve as signaling molecules [<xref ref-type="bibr" rid="B30-ijms-20-04160">30</xref>].</p>
<p>Intracerebroventricular injection of propionate in rodents was found to cause social impairment [<xref ref-type="bibr" rid="B31-ijms-20-04160">31</xref>], as well as behavioral, neuropathological, and biochemical changes associated with ASD [<xref ref-type="bibr" rid="B32-ijms-20-04160">32</xref>]. However, the contribution of microbial metabolites to ASD still must be elucidated, taking into account that fecal SCFAs were reported to be either lower or higher in ASD children [<xref ref-type="bibr" rid="B15-ijms-20-04160">15</xref>,<xref ref-type="bibr" rid="B33-ijms-20-04160">33</xref>,<xref ref-type="bibr" rid="B34-ijms-20-04160">34</xref>]. </p>
<p>Among genetic NDs, down syndrome (OMIM #190685, trisomy 21–DS) is the most frequent cause of intellectual disability (ID). ASD features and the high prevalence of gastrointestinal system alterations (about 50%) often characterize DS individuals [<xref ref-type="bibr" rid="B35-ijms-20-04160">35</xref>]. Despite DS incidence and the suggestive features of a possible gut microbiota modulation, only one study has investigated the DS gut microbial community thus far. Biagi and coworkers [<xref ref-type="bibr" rid="B36-ijms-20-04160">36</xref>] compared 17 DS adults with a matched group of healthy controls. The authors reported specific changes in the microbial community of individuals affected by DS, with some of them being associated with behavioral traits. Although DS gut microbiota does not significantly differ in the relative abundance of the dominant microbial families (i.e., <italic>Ruminococcaceae, Lachnospiraceae, Clostridiales, Bifidobacteriaceae</italic>, and <italic>Bacteroidaceae</italic>), some subdominant taxa are differently represented in DS compared with healthy controls. In particular, the relative abundance of <italic>Parasporobacterium</italic> spp. and <italic>Sutterella</italic> spp. is increased, whereas <italic>Veillonellaceae</italic> is reduced. Besides, when considering the severity of neurobehavioral manifestations in DS patients, <italic>Sutterella</italic> was positively correlated with the aberrant behavior checklist (ABC) total score, while no correlation was found between ABC and <italic>Parasporobacterium</italic> or <italic>Veillonellaceae</italic>.</p>
</sec>
<sec id="sec3-ijms-20-04160">
<title>3. Gut Microbiome Alterations in Rett Syndrome</title>
<p>Although Rett syndrome (RTT) is no longer categorized as a pervasive developmental disorder, patients share certain features with ASD. RTT (OMIM #312750) is an X-linked dominant neurodevelopmental disorder and one of the most common causes of ID in females. Of all cases, 90–95% are associated with pathogenic variants in the <italic>MECP2</italic> (Methyl CpG Binding Protein 2) gene, encoding a chromatin-associated protein that can both activate and repress transcription [<xref ref-type="bibr" rid="B37-ijms-20-04160">37</xref>,<xref ref-type="bibr" rid="B38-ijms-20-04160">38</xref>]. The RTT core phenotype mainly consists of neurological problems (partial/complete loss of acquired purposeful hand skills; partial/complete loss of acquired spoken language; gait abnormalities; stereotypic hand movements) [<xref ref-type="bibr" rid="B39-ijms-20-04160">39</xref>]. Most girls affected by RTT experience epileptic seizures, with epilepsy representing a major concern of RTT caregivers and having a crucial impact on children and their family’s quality of life [<xref ref-type="bibr" rid="B40-ijms-20-04160">40</xref>]. In addition to epilepsy, parental stress is affected by their daughters’ GI pain experience [<xref ref-type="bibr" rid="B41-ijms-20-04160">41</xref>]. Indeed, one of the major issues impacting patients affected by RTT on a daily basis is represented by gastrointestinal and nutritional problems [<xref ref-type="bibr" rid="B42-ijms-20-04160">42</xref>]. Families reported a series of different symptoms, such as straining with bowel movements, the passage of hard stools, constipation, and prolonged feeding time or chewing difficulty in more than 50% of RTT patients [<xref ref-type="bibr" rid="B42-ijms-20-04160">42</xref>]. More recently, cholelithiasis, or gallbladder disease, has been reported to be relatively frequent in RTT, and should be considered one of the causes of abdominal pain [<xref ref-type="bibr" rid="B43-ijms-20-04160">43</xref>]. Due to the high frequency of gastrointestinal comorbidities, recommendations for managing GI symptoms have been recently developed [<xref ref-type="bibr" rid="B44-ijms-20-04160">44</xref>]. </p>
<p>Despite the similar features with ASD and the observation of the frequent gastrointestinal discomfort reported by RTT caregivers, the study of possible microbial alterations characterizing RTT gut microbiota is still relatively new. Only two Italian groups have investigated this aspect in RTT girls thus far. The characteristics and main results of these studies are outlined in <xref ref-type="table" rid="ijms-20-04160-t001">Table 1</xref>. </p>
<p>Because of the higher vulnerability to respiratory infections related both to RTT itself and to the different associated comorbidities (e.g. scoliosis, epilepsy, ID) [<xref ref-type="bibr" rid="B45-ijms-20-04160">45</xref>], subjects with RTT may be exposed to several antibiotics to prevent/cure recurrent respiratory infections. Antibiotics are responsible for altering the gut microbiome. For this reason, in the studies conducted on RTT girls, a common exclusion criterion was an antibiotic assumption in the three months preceding the collection of the sample.</p>
<p>RTT gut microbiota is characterized by a reduction in α-diversity [<xref ref-type="bibr" rid="B46-ijms-20-04160">46</xref>,<xref ref-type="bibr" rid="B47-ijms-20-04160">47</xref>]. α-diversity metrics allow studying the richness, i.e., the number of unique microbial taxa within a given sample, as well as the evenness, how uniformly the unique taxa are distributed, and the phylogenetic relatedness between them. The loss of microbial diversity is considered a hallmark of dysbiosis, paving the way to a reduced gut microbiota resilience [<xref ref-type="bibr" rid="B48-ijms-20-04160">48</xref>]. Thus, the gut microbial ecosystem of RTT girls can be considered intrinsically more susceptible to disease status. The decrease in diversity observed in RTT patients is more pronounced in severe phenotypes, as patients with a lower diversity have higher clinical severity scale (CSS) scores [<xref ref-type="bibr" rid="B47-ijms-20-04160">47</xref>]. </p>
<p>β-diversity (Unifrac distances) analyses, which measure dissimilarities in microbial community composition between samples, showed that RTT gut microbial community clustered according to the disease status. On the one hand, Strati and coworkers grouped RTT patients according to GI dysfunction and observed that health status, not GI symptoms, distinguish the patients from healthy controls, whereas constipated RTT and non-constipated RTT were not statistically different. On the other hand, the severity of the disease further stratified RTT patients [<xref ref-type="bibr" rid="B47-ijms-20-04160">47</xref>]. In particular, unweighted Unifrac metric, which considers both rare and common bacterial taxa, highlighted a significant dissimilarity between the RTT and healthy subjects, suggesting that, as described for DS [<xref ref-type="bibr" rid="B36-ijms-20-04160">36</xref>], subdominant taxa are differently represented. The analyses on the relative microbial abundance at different taxonomic levels showed an enrichment in <italic>Erysipelotrichacea</italic>e in RTT patients and, at the genus level, of <italic>Clostridium</italic> spp., <italic>Sutterella</italic> spp., and <italic>Escherichia</italic> spp. [<xref ref-type="bibr" rid="B46-ijms-20-04160">46</xref>,<xref ref-type="bibr" rid="B47-ijms-20-04160">47</xref>]. Other taxa were found to be discordant between the two studies, i.e., <italic>Bifidobacterium</italic> and <italic>Bacteroides</italic>. Bifidobacteria data could suffer from an age-related abundance. Indeed, Strati et al. enrolled younger girls affected by RTT, with a consistent number of children younger than 10 years old. This taxon is well-known to inversely correlate with age, with the highest abundance during lactation [<xref ref-type="bibr" rid="B49-ijms-20-04160">49</xref>]. Like the microbial alterations reported in ASD patients, Borghi et al. observed a decrease in <italic>Bacteroides</italic> spp. [<xref ref-type="bibr" rid="B47-ijms-20-04160">47</xref>]. This genus, as well as Bacteroidetes, are reported to be negatively correlated with body-mass index (BMI) [<xref ref-type="bibr" rid="B50-ijms-20-04160">50</xref>,<xref ref-type="bibr" rid="B51-ijms-20-04160">51</xref>,<xref ref-type="bibr" rid="B52-ijms-20-04160">52</xref>]. BMI values were lower in the RTT group, justifying this observation. Anthropometric measurements were not specified in the second cohort. Despite differences in the observed taxa relative abundances in the two studies, a common increase in the fecal concentration of branched-chain fatty acids (iso-butyrate and iso-valerate-BCFAs) and, to a lesser extent, of propionate and butyrate, has been observed. BCFAs are byproducts of protein degradation, especially of animal proteins that are rich in branched-chain amino acids, by proteolytic bacteria such as Bacteroidetes. Dietary survey [<xref ref-type="bibr" rid="B47-ijms-20-04160">47</xref>] showed a higher protein consumption, mainly due to higher animal protein intake, and a lower fiber intake in RTT compared with healthy controls. No specific dietary recommendations for RTT patients have been reported so far, but proteins might be preferred for the increased ratio nutrients/volume, considering eating difficulties, palatability, and texture. Beside BCFAs, proteolysis results in the production of phenolic and indolic compounds. As already mentioned for ASD, p-cresol, the main phenolic product, is a toxic compound and has been demonstrated to be able to alter the intestinal barrier permeability [<xref ref-type="bibr" rid="B53-ijms-20-04160">53</xref>]. Although no study has evaluated its fecal or urinary concentrations in RTT subjects to date, the enrichment in gut microbiota in the main producing species, i.e., <italic>Clostridium</italic> spp. [<xref ref-type="bibr" rid="B46-ijms-20-04160">46</xref>,<xref ref-type="bibr" rid="B47-ijms-20-04160">47</xref>] <italic>Bacteroides</italic> spp. [<xref ref-type="bibr" rid="B47-ijms-20-04160">47</xref>], suggests a possible increase of p-cresol also in RTT.</p>
<p>Mouse models of RTT are available and they recapitulate several neurological features observed in patients [<xref ref-type="bibr" rid="B54-ijms-20-04160">54</xref>], including altered cortical rhythms and enhanced susceptibility to epileptic seizures [<xref ref-type="bibr" rid="B55-ijms-20-04160">55</xref>,<xref ref-type="bibr" rid="B56-ijms-20-04160">56</xref>]. Moreover, severe modifications in the colon organization are present in MeCP2 mutant mice [<xref ref-type="bibr" rid="B57-ijms-20-04160">57</xref>], suggesting that alterations occurring at the gut level, including gut microbiome, could be associated with the classical neurological impairments observed in RTT mice. Despite this evidence, the gut microbiota of RTT mouse models has not been explored to date, and the aspects related to the gut microbiome-brain axis in this murine model have not been examined.</p>
</sec>
<sec id="sec4-ijms-20-04160">
<title>4. Gut Microbiome Alterations in Epilepsy</title>
<p>Both RTT and ASD are often comorbid with seizure disorders [<xref ref-type="bibr" rid="B58-ijms-20-04160">58</xref>]. Although it is not mentioned in the diagnostic criteria [<xref ref-type="bibr" rid="B39-ijms-20-04160">39</xref>], up to 70% of girls affected by RTT experience frequent seizures, and 30% of them are resistant to the available antiepileptic drugs (AEDs) [<xref ref-type="bibr" rid="B59-ijms-20-04160">59</xref>]. In classic RTT, the mean age of epilepsy onset is 4 years. Seizure frequency and severity usually have an age-dependent course, as girls aged 10–14 years are the most difficult to treat and often require AED polytherapy [<xref ref-type="bibr" rid="B60-ijms-20-04160">60</xref>]. Recent findings from the Rett Natural History Study pointed out that seizures in RTT may show a pattern of remission and relapse within the lifetime. Specific <italic>MECP2</italic> mutations are not significantly associated with either seizure prevalence or seizure severity, although seizure prevalence is associated with disease severity [<xref ref-type="bibr" rid="B61-ijms-20-04160">61</xref>].</p>
<p>The potential role of gut microbiota in epilepsy is currently emerging. He et al. [<xref ref-type="bibr" rid="B62-ijms-20-04160">62</xref>] studied a patient with a 17-year history of epilepsy, which improved after fecal microbiota transplantation treatment for Crohn’s disease. More recently, the gut microbial community in patients with drug-resistant epilepsy was found to be significantly altered with an abnormally increased abundance of rare bacteria mainly belonging from the phylum Firmicutes. On the contrary, the gut microbiome of patients with drug-sensitive epilepsy was more similar to that of healthy controls. Therefore, it can be speculated that gut dysbiosis may be involved in the pathogenesis of drug-resistant epilepsy [<xref ref-type="bibr" rid="B63-ijms-20-04160">63</xref>]. In particular, patients with seizures responsive to AEDs have a greater amount of bifidobacteria and lactobacilli, which could be interpreted as protective factors for epilepsy [<xref ref-type="bibr" rid="B63-ijms-20-04160">63</xref>]. Indeed, a recent study on drug-resistant epilepsy showed that probiotic supplementation with a mixture of bifidobacteria and lactobacilli reduces both seizures and sCD14 serum concentration, a recognized marker for bacterial translocation [<xref ref-type="bibr" rid="B64-ijms-20-04160">64</xref>].</p>
<p>Many drugs have been demonstrated to modulate or alter the gut microbial community. In particular, compounds targeting the nervous system exhibited a significant anticommensal activity on a broad range of microorganisms [<xref ref-type="bibr" rid="B65-ijms-20-04160">65</xref>]. Although the direct role of AEDs has not been investigated to date, it is plausible, although not yet elucidated [<xref ref-type="bibr" rid="B47-ijms-20-04160">47</xref>].</p>
<p>Other pieces of evidence based on diet modification support the possible role of gut microbiota in modulating epilepsy. The ketogenic diet (KD) is a high-fat, adequate-protein, low-carbohydrate diet used as a treatment for neurometabolic disorders, such as glucose transporter 1 (Glut1)-deficiency syndrome, and for drug-resistant epilepsy. Considering the unbalanced macronutrient composition of the KD, it is expected to induce some changes in gut microbiota. Tagliabue et al. [<xref ref-type="bibr" rid="B66-ijms-20-04160">66</xref>] evaluated the gut microbiota composition in six children with Glut1-deficiency syndrome after three months of KD treatment and did not find statistically significant differences in Firmicutes and Bacteroidetes. However, they found a statistically significant increase in <italic>Desulfovibrio</italic> spp., a subdominant taxon reported in inflammatory bowel disease and other inflammatory conditions [<xref ref-type="bibr" rid="B67-ijms-20-04160">67</xref>].</p>
<p>Xie and coworkers [<xref ref-type="bibr" rid="B68-ijms-20-04160">68</xref>] found that the gut microbiota of Chinese epileptic children differed from age-matched healthy infants and reported that the KD strongly improved gut microbiota alterations, promoting seizure reductions. Another study, which enrolled 20 children with refractory epilepsy, observed distinctive microbial changes in KD-responder (seizure-free or ≥ 50% of seizure reduction) and non-responder patients (&lt;50% of seizure reduction). The KD-responders were characterized by an increase in the relative abundance of Bacteroidetes, whereas non-responders showed a significant increase in the relative abundance of the Firmicutes (<italic>Clostridiales</italic>, <italic>Clostridia, Ruminococcaceae, Lachnospiraceae, Alistipes</italic>, and <italic>Rikenellaceae</italic>) [<xref ref-type="bibr" rid="B69-ijms-20-04160">69</xref>]. A further study on KD treatment for severe epilepsy in Swedish children, which applied a shotgun metagenomic DNA sequencing approach, found that alpha diversity was not significantly changed by diet. The study highlighted a decrease in the relative abundance of Actinobacteria and Firmicutes, and an increase of Bacteroidetes and Proteobacteria [<xref ref-type="bibr" rid="B70-ijms-20-04160">70</xref>]. Intriguingly, microbiota changes were linked to functional changes, particularly in relation to carbohydrates metabolism pathways. </p>
<p>The KD has been investigated as a possible intervention in RTT [<xref ref-type="bibr" rid="B71-ijms-20-04160">71</xref>], especially in the <italic>CDKL5</italic>-related variant, which is characterized by multiple seizure-type epilepsy and a poor response to AEDs [<xref ref-type="bibr" rid="B72-ijms-20-04160">72</xref>]. Major concerns to a broad application of the KD are the reported poor long-term efficacy and lack of adherence. </p>
<p>Despite the growing number of studies on the KD and its impact on microbiota in epilepsy, the findings should be interpreted with caution because of the small number of patients involved, the different epilepsy etiology, and the specific diet composition. Nevertheless, the accumulating evidence suggests the need for a better understanding of the state of dysbiosis to establish strategies to possibly counterbalance it. </p>
</sec>
<sec id="sec5-ijms-20-04160" sec-type="discussion">
<title>5. Discussion</title>
<p>Intriguingly, neurodevelopmental disorders sharing clinical features display a microbial signature or are at least enriched/depleted in the same taxa. The major overlaps, both clinical and microbial, are highlighted in the Venn diagram (<xref ref-type="fig" rid="ijms-20-04160-f001">Figure 1</xref>).</p>
<p>The diagram was generated (<uri xlink:href="http://bioinfogp.cnb.csic.es/tools/venny/index.html">http://bioinfogp.cnb.csic.es/tools/venny/index.html</uri>) considering only microbial changes reported in most studies (i.e., discarding discordant findings).</p>
<p>In particular, an enrichment in <italic>Sutterella</italic> spp. has been reported in all the reviewed NDs. A similar trend was also observed in attention-deficit/hyperactivity disorder (ADHD) [<xref ref-type="bibr" rid="B73-ijms-20-04160">73</xref>] and in rodent models with Alzheimer’s disease [<xref ref-type="bibr" rid="B74-ijms-20-04160">74</xref>] and ASD [<xref ref-type="bibr" rid="B75-ijms-20-04160">75</xref>]. <italic>Sutterella</italic> belongs to Beta-proteobacteria, gram-negative bacterium. Due to the reported higher relative abundance in several human diseases, Hiippala and coworkers [<xref ref-type="bibr" rid="B76-ijms-20-04160">76</xref>] assessed its in vitro pro-inflammatory activity and compared it with the well-known <italic>Escherichia coli</italic> (gamma-Proteobacteria). <italic>Sutterella</italic> demonstrated only a mild pro-inflammatory activity on intestinal epithelial cells, which was not sufficient to induce GI homeostasis alterations. On the other hand, this taxon was demonstrated to efficiently adhere to enterocytes [<xref ref-type="bibr" rid="B77-ijms-20-04160">77</xref>], and the effect of a direct cross-talk with these cells in the frame of the gut-brain-axis warrants further elucidation. </p>
<p>Similarly, RTT and ASD subjects share an increase in the relative abundance of <italic>Clostridium</italic> spp. This taxon, together with <italic>Bacteroides</italic> spp., is well-known for its proteolytic ability, which results in potentially toxic compounds that can impact on gut homeostasis and permeability [<xref ref-type="bibr" rid="B53-ijms-20-04160">53</xref>] and can affect the survival of other beneficial microorganisms, such as lactic bacteria [<xref ref-type="bibr" rid="B77-ijms-20-04160">77</xref>]. Bifidobacteria and lactobacilli are known to be able to secrete neurotransmitters, particularly the gamma-aminobutyric acid (GABA) [<xref ref-type="bibr" rid="B78-ijms-20-04160">78</xref>]. A decrease in GABA and its signaling is suggested to be involved in many ND-associated clinical features, i.e., stereotypies, hypersensitivities, and seizures [<xref ref-type="bibr" rid="B79-ijms-20-04160">79</xref>,<xref ref-type="bibr" rid="B80-ijms-20-04160">80</xref>,<xref ref-type="bibr" rid="B81-ijms-20-04160">81</xref>]. Moreover, the same taxa have been shown to promote intestinal mucosa integrity [<xref ref-type="bibr" rid="B82-ijms-20-04160">82</xref>], decreasing local and systemic inflammatory status. CNS is highly susceptible to inflammation, contributing to the pathogenesis of RTT [<xref ref-type="bibr" rid="B83-ijms-20-04160">83</xref>] and to associated comorbidities. In particular, neuroinflammation has been demonstrated to trigger seizures in patients with epilepsy [<xref ref-type="bibr" rid="B84-ijms-20-04160">84</xref>]. A direct role of gut microbiota in eliciting inflammation and, in turn, seizure occurrence, has been postulated and investigated in animal models [<xref ref-type="bibr" rid="B85-ijms-20-04160">85</xref>]. </p>
<p>Although speculative conclusions about microbiota-dependent modifications in brain function and behaviors have been raised over recent years (summarized in the context of NDs in <xref ref-type="fig" rid="ijms-20-04160-f002">Figure 2</xref>), no studies have directly assessed the molecular or neurophysiological mechanisms responsible for neurodevelopmental alterations characteristic of NDs [<xref ref-type="bibr" rid="B86-ijms-20-04160">86</xref>].</p>
<p>Most of the literature has focused either on the clinical aspect or on the microbiome alterations. Nevertheless, NDs are characterized by multifaceted phenotypes that might contribute to the observed differences in the microbiota among various cohorts. A comprehensive approach, combining detailed clinical description with microbiological data, is needed to better understand underlying relationships between symptoms and specific microbial alterations.</p>
</sec>
<sec id="sec6-ijms-20-04160">
<title>6. Conclusions</title>
<p>Although microbiome studies in RTT patients are in their early stages, several authors have investigated this aspect in ASD, which shares several clinical similarities with RTT. Main changes in the gut microbial community suggest enrichment in pro-inflammatory species that could promote alterations in the gut permeability and its barrier function. Within the context of the gut-brain axis, these microbiota-dependent modifications could trigger common behavioral and neurodevelopmental features. </p>
<p>The observation of the presence of a dysbiosis in patients with NDs, especially ASD, triggers the development of innovative therapeutic strategies throughout microbiome-based treatment. Nevertheless, clinical trials with probiotic supplementation are currently limited and lack standardized probiotic regimen, i.e., different administered strains or concentrations and duration of treatment. No clinical trials have been carried out on RTT cohorts thus far.</p>
<p>In addition to probiotic intervention, a careful diet survey on large cohorts of RTT patients would allow the development of diet recommendations that might mitigate microbiome alterations per se. </p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>The authors thank Angela Peron for reviewing the manuscript.</p>
</ack>
<notes>
<title>Author Contributions</title>
<p>E.B. and A.V. conceptualized, wrote, and reviewed the article. </p>
</notes>
<notes>
<title>Funding</title>
<p>The FFABR 2017 grant by the Italian Ministry of Education, Universities and Research to A.V. covered the costs to publish in open access.</p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no conflict of interest.</p>
</notes>
<glossary>
<title>Abbreviations</title>
<array orientation="portrait">
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">AED</td>
<td align="left" colspan="1" rowspan="1" valign="top">Antiepileptic drug</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ASD</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism spectrum disorder</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">BCFA</td>
<td align="left" colspan="1" rowspan="1" valign="top">Branched-chain fatty acids</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">CDKL5</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cyclin-dependent kinase-like 5</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">CNS</td>
<td align="left" colspan="1" rowspan="1" valign="top">Central nervous system</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">CSS</td>
<td align="left" colspan="1" rowspan="1" valign="top">Clinical severity score</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">DS</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down syndrome</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">GABA</td>
<td align="left" colspan="1" rowspan="1" valign="top">Gamma aminobutyric acid</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">GI</td>
<td align="left" colspan="1" rowspan="1" valign="top">Gastrointestinal tract</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ID</td>
<td align="left" colspan="1" rowspan="1" valign="top">Intellectual disability</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">KD</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ketogenic diet</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">MeCP2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Methyl CpG binding protein 2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">ND</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurodevelopmental disorder</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">RTT</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rett syndrome</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="middle">SCFA</td>
<td align="left" colspan="1" rowspan="1" valign="top">Short-chain fatty acids</td>
</tr>
</tbody>
</array>
</glossary>
<ref-list>
<title>References</title>
<ref id="B1-ijms-20-04160">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Round</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Mazmanian</surname>
<given-names>S.K.</given-names>
</name>
</person-group>
<article-title>The gut microbiota shapes intestinal immune responses during health and disease</article-title>
<source/>Nat. Rev. Immunol.
          <year>2009</year>
<volume>9</volume>
<fpage>313</fpage>
<lpage>323</lpage>
<pub-id pub-id-type="doi">10.1038/nri2515</pub-id>
<pub-id pub-id-type="pmid">19343057</pub-id>
</element-citation>
</ref>
<ref id="B2-ijms-20-04160">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharon</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sampson</surname>
<given-names>T.R.</given-names>
</name>
<name>
<surname>Geschwind</surname>
<given-names>D.H.</given-names>
</name>
<name>
<surname>Mazmanian</surname>
<given-names>S.K.</given-names>
</name>
</person-group>
<article-title>Central Nervous System and the Gut Microbiome</article-title>
<source/>Cell
          <year>2016</year>
<volume>167</volume>
<fpage>915</fpage>
<lpage>932</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2016.10.027</pub-id>
<pub-id pub-id-type="pmid">27814521</pub-id>
</element-citation>
</ref>
<ref id="B3-ijms-20-04160">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sommer</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bäckhed</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>The gut microbiota--masters of host development and physiology</article-title>
<source/>Nat. Rev. Microbiol.
          <year>2013</year>
<volume>11</volume>
<fpage>227</fpage>
<lpage>238</lpage>
<pub-id pub-id-type="doi">10.1038/nrmicro2974</pub-id>
<pub-id pub-id-type="pmid">23435359</pub-id>
</element-citation>
</ref>
<ref id="B4-ijms-20-04160">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bercik</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Denou</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jury</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Blennerhassett</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Macri</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>McCoy</surname>
<given-names>K.D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The intestinal microbiota affects central levels of brain-derived neurotropic factor and behavior in mice</article-title>
<source/>Gastroenterology
          <year>2011</year>
<volume>141</volume>
<fpage>599</fpage>
<lpage>609</lpage>
<pub-id pub-id-type="doi">10.1053/j.gastro.2011.04.052</pub-id>
<pub-id pub-id-type="pmid">21683077</pub-id>
</element-citation>
</ref>
<ref id="B5-ijms-20-04160">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Erny</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hrabe de Angelis</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Jaitin</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wieghofer</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Staszewski</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>David</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Keren-Shaul</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Mahlakoiv</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Jakobshagen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Buch</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Host microbiota constantly control maturation and function of microglia in the CNS</article-title>
<source/>Nat. Neurosci.
          <year>2015</year>
<volume>18</volume>
<fpage>965</fpage>
<lpage>977</lpage>
<pub-id pub-id-type="doi">10.1038/nn.4030</pub-id>
<pub-id pub-id-type="pmid">26030851</pub-id>
</element-citation>
</ref>
<ref id="B6-ijms-20-04160">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Braniste</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Al-Asmakh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kowal</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Anuar</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Abbaspour</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tòth</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Korecka</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bakocevic</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>L.G.</given-names>
</name>
<name>
<surname>Kundu</surname>
<given-names>P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The gut microbiota influences blood-brain barrier permeability in mice</article-title>
<source/>Sci. Transl. Med.
          <year>2014</year>
<volume>6</volume>
<fpage>263ra158</fpage>
<pub-id pub-id-type="doi">10.1126/scitranslmed.3009759</pub-id>
<pub-id pub-id-type="pmid">25411471</pub-id>
</element-citation>
</ref>
<ref id="B7-ijms-20-04160">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoban</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Stilling</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>F.J.</given-names>
</name>
<name>
<surname>Shanahan</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Dinan</surname>
<given-names>T.G.</given-names>
</name>
<name>
<surname>Claesson</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cryan</surname>
<given-names>J.F.</given-names>
</name>
</person-group>
<article-title>Regulation of prefrontal cortex myelination by the microbiota</article-title>
<source/>Transl. Psychiatry
          <year>2016</year>
<volume>6</volume>
<fpage>e774</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2016.42</pub-id>
<pub-id pub-id-type="pmid">27045844</pub-id>
</element-citation>
</ref>
<ref id="B8-ijms-20-04160">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diaz Heijtz</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Anuar</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Björkholm</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Samuelsson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hibberd</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Forssberg</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Pettersson</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Normal gut microbiota modulates brain development and behavior</article-title>
<source/>Proc. Natl. Acad. Sci. USA.
          <year>2011</year>
<volume>108</volume>
<fpage>3047</fpage>
<lpage>3052</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1010529108</pub-id>
<pub-id pub-id-type="pmid">21282636</pub-id>
</element-citation>
</ref>
<ref id="B9-ijms-20-04160">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mayer</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Savidge</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shulman</surname>
<given-names>R.J.</given-names>
</name>
</person-group>
<article-title>Brain-gut microbiome interactions and functional bowel disorders</article-title>
<source/>Gastroenterology
          <year>2014</year>
<volume>146</volume>
<fpage>1500</fpage>
<lpage>1512</lpage>
<pub-id pub-id-type="doi">10.1053/j.gastro.2014.02.037</pub-id>
<pub-id pub-id-type="pmid">24583088</pub-id>
</element-citation>
</ref>
<ref id="B10-ijms-20-04160">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ismail</surname>
<given-names>F.Y.</given-names>
</name>
<name>
<surname>Shapiro</surname>
<given-names>B.K.</given-names>
</name>
</person-group>
<article-title>What are neurodevelopmental disorders?</article-title>
<source/>Curr. Opin. Neurol.
          <year>2019</year>
<volume>32</volume>
<fpage>611</fpage>
<lpage>616</lpage>
<pub-id pub-id-type="doi">10.1097/WCO.0000000000000710</pub-id>
<pub-id pub-id-type="pmid">31116115</pub-id>
</element-citation>
</ref>
<ref id="B11-ijms-20-04160">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elsabbagh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Divan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Koh</surname>
<given-names>Y.J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y.S.</given-names>
</name>
<name>
<surname>Kauchali</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Marcín</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Montiel-Nava</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Paula</surname>
<given-names>C.S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Global prevalence of autism and other pervasive developmental disorders</article-title>
<source/>Autism. Res.
          <year>2012</year>
<volume>5</volume>
<fpage>160</fpage>
<lpage>179</lpage>
<pub-id pub-id-type="doi">10.1002/aur.239</pub-id>
<pub-id pub-id-type="pmid">22495912</pub-id>
</element-citation>
</ref>
<ref id="B12-ijms-20-04160">
<label>12.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>American Psychiatric Association</collab>
</person-group>
<source/>American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders
          <edition>5th ed.</edition>
<publisher-name>American Psychiatric Association</publisher-name>
<publisher-loc>Arlington County, VA, USA</publisher-loc>
<year>2013</year>
</element-citation>
</ref>
<ref id="B13-ijms-20-04160">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marler</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ferguson</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>E.B.</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>K.C.</given-names>
</name>
<name>
<surname>McDonnell</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Macklin</surname>
<given-names>E.A.</given-names>
</name>
<name>
<surname>Levitt</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Margolis</surname>
<given-names>K.G.</given-names>
</name>
<name>
<surname>Beversdorf</surname>
<given-names>D.Q.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association of Rigid-Compulsive Behavior with Functional Constipation in Autism Spectrum Disorder</article-title>
<source/>J. Autism. Dev. Disord.
          <year>2017</year>
<volume>47</volume>
<fpage>1673</fpage>
<lpage>1681</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-017-3084-6</pub-id>
<pub-id pub-id-type="pmid">28289979</pub-id>
</element-citation>
</ref>
<ref id="B14-ijms-20-04160">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holingue</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Newill</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Pasricha</surname>
<given-names>P.J.</given-names>
</name>
<name>
<surname>Daniele Fallin</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Gastrointestinal symptoms in autism spectrum disorder: A review of the literature on ascertainment and prevalence</article-title>
<source/>Autism. Res.
          <year>2018</year>
<volume>11</volume>
<fpage>24</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="doi">10.1002/aur.1854</pub-id>
<pub-id pub-id-type="pmid">28856868</pub-id>
</element-citation>
</ref>
<ref id="B15-ijms-20-04160">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adams</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Johansen</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>L.D.</given-names>
</name>
<name>
<surname>Quig</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Rubin</surname>
<given-names>R.A.</given-names>
</name>
</person-group>
<article-title>Gastrointestinal flora and gastrointestinal status in children with autism–comparisons to typical children and correlation with autism severity</article-title>
<source/>BMC Gastroenterol.
          <year>2011</year>
<volume>16</volume>
<fpage>11</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1186/1471-230X-11-22</pub-id>
<pub-id pub-id-type="pmid">21410934</pub-id>
</element-citation>
</ref>
<ref id="B16-ijms-20-04160">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nikolov</surname>
<given-names>R.N.</given-names>
</name>
<name>
<surname>Bearss</surname>
<given-names>K.E.</given-names>
</name>
<name>
<surname>Lettinga</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Erickson</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rodowski</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Aman</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>McCracken</surname>
<given-names>J.T.</given-names>
</name>
<name>
<surname>McDougle</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Tierney</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Vitiello</surname>
<given-names>B.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gastrointestinal symptoms in a sample of children with pervasive developmental disorders</article-title>
<source/>J. Autism. Develop. Disord.
          <year>2009</year>
<volume>39</volume>
<fpage>405</fpage>
<lpage>413</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-008-0637-8</pub-id>
<pub-id pub-id-type="pmid">18791817</pub-id>
</element-citation>
</ref>
<ref id="B17-ijms-20-04160">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kohane</surname>
<given-names>I.S.</given-names>
</name>
<name>
<surname>McMurry</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Weber</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>MacFadden</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Rappaport</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kunkel</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bickel</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wattanasin</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Spence</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The co-morbidity burden of children and young adults with autism spectrum disorders</article-title>
<source/>PLoS ONE
          <year>2012</year>
<volume>7</volume>
<elocation-id>e33224</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0033224</pub-id>
<pub-id pub-id-type="pmid">22511918</pub-id>
</element-citation>
</ref>
<ref id="B18-ijms-20-04160">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Ilhan</surname>
<given-names>Z.E.</given-names>
</name>
<name>
<surname>Wallstrom</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Labaer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Krajmalnik-Brown</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<elocation-id>e68322</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0068322</pub-id>
<pub-id pub-id-type="pmid">23844187</pub-id>
</element-citation>
</ref>
<ref id="B19-ijms-20-04160">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Christophersen</surname>
<given-names>C.T.</given-names>
</name>
<name>
<surname>Sorich</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Gerber</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Angley</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Conlon</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Increased abundance of Sutterella spp. and Ruminococcus torques in feces of children with autism spectrum disorder</article-title>
<source/>Mol. Autism.
          <year>2013</year>
<volume>4</volume>
<fpage>42</fpage>
<pub-id pub-id-type="doi">10.1186/2040-2392-4-42</pub-id>
<pub-id pub-id-type="pmid">24188502</pub-id>
</element-citation>
</ref>
<ref id="B20-ijms-20-04160">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Argou-Cardozo</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Zeidán-Chuliá</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Clostridium Bacteria and Autism Spectrum Conditions: A Systematic Review and Hypothetical Contribution of Environmental Glyphosate Levels</article-title>
<source/>Med. Sci. (Basel)
          <year>2018</year>
<volume>6</volume>
<elocation-id>E29</elocation-id>
<pub-id pub-id-type="doi">10.3390/medsci6020029</pub-id>
<pub-id pub-id-type="pmid">29617356</pub-id>
</element-citation>
</ref>
<ref id="B21-ijms-20-04160">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname>
<given-names>H.T.</given-names>
</name>
<name>
<surname>Taur</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Walkup</surname>
<given-names>J.T.</given-names>
</name>
</person-group>
<article-title>Gut Microbiota and Autism: Key Concepts and Findings</article-title>
<source/>J. Autism Dev. Disord.
          <year>2017</year>
<volume>47</volume>
<fpage>480</fpage>
<lpage>489</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-016-2960-9</pub-id>
<pub-id pub-id-type="pmid">27882443</pub-id>
</element-citation>
</ref>
<ref id="B22-ijms-20-04160">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Altered composition and function of intestinal microbiota in autism spectrum disorders: A systematic review</article-title>
<source/>Transl. Psychiatry
          <year>2019</year>
<volume>9</volume>
<fpage>43</fpage>
<pub-id pub-id-type="doi">10.1038/s41398-019-0389-6</pub-id>
<pub-id pub-id-type="pmid">30696816</pub-id>
</element-citation>
</ref>
<ref id="B23-ijms-20-04160">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Angelis</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Piccolo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Vannini</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Siragusa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>De Giacomo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Serrazzanetti</surname>
<given-names>D.I.</given-names>
</name>
<name>
<surname>Cristofori</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Guerzoni</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Gobbetti</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Francavilla</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified</article-title>
<source/>PLoS ONE
          <year>2013</year>
<volume>8</volume>
<elocation-id>e76993</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0076993</pub-id>
<pub-id pub-id-type="pmid">24130822</pub-id>
</element-citation>
</ref>
<ref id="B24-ijms-20-04160">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finegold</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Dowd</surname>
<given-names>S.E.</given-names>
</name>
<name>
<surname>Gontcharova</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Henley</surname>
<given-names>K.E.</given-names>
</name>
<name>
<surname>Youn</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Summanen</surname>
<given-names>P.H.</given-names>
</name>
<name>
<surname>Granpeesheh</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dixon</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pyrosequencing study of fecal microflora of autistic and control children</article-title>
<source/>Anaerobe
          <year>2010</year>
<volume>16</volume>
<fpage>444</fpage>
<lpage>453</lpage>
<pub-id pub-id-type="doi">10.1016/j.anaerobe.2010.06.008</pub-id>
<pub-id pub-id-type="pmid">20603222</pub-id>
</element-citation>
</ref>
<ref id="B25-ijms-20-04160">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bolte</surname>
<given-names>E.R.</given-names>
</name>
</person-group>
<article-title>Autism and Clostridium tetani</article-title>
<source/>Med. Hypotheses
          <year>1998</year>
<volume>51</volume>
<fpage>133</fpage>
<lpage>144</lpage>
<pub-id pub-id-type="doi">10.1016/S0306-9877(98)90107-4</pub-id>
<pub-id pub-id-type="pmid">9881820</pub-id>
</element-citation>
</ref>
<ref id="B26-ijms-20-04160">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Finegold</surname>
<given-names>S.M.</given-names>
</name>
</person-group>
<article-title>Real-time PCR quantitation of clostridia in feces of autistic children</article-title>
<source/>Appl. Environ. Microbiol.
          <year>2004</year>
<volume>70</volume>
<fpage>6459</fpage>
<lpage>6465</lpage>
<pub-id pub-id-type="doi">10.1128/AEM.70.11.6459-6465.2004</pub-id>
<pub-id pub-id-type="pmid">15528506</pub-id>
</element-citation>
</ref>
<ref id="B27-ijms-20-04160">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Finegold</surname>
<given-names>S.M.</given-names>
</name>
</person-group>
<article-title>Therapy and epidemiology of autism-clostridial spores as key elements</article-title>
<source/>Med. Hypotheses
          <year>2008</year>
<volume>70</volume>
<fpage>508</fpage>
<lpage>511</lpage>
<pub-id pub-id-type="doi">10.1016/j.mehy.2007.07.019</pub-id>
<pub-id pub-id-type="pmid">17904761</pub-id>
</element-citation>
</ref>
<ref id="B28-ijms-20-04160">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stiles</surname>
<given-names>B.G.</given-names>
</name>
<name>
<surname>Pradhan</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fleming</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Samy</surname>
<given-names>R.P.</given-names>
</name>
<name>
<surname>Barth</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Popoff</surname>
<given-names>M.R.</given-names>
</name>
</person-group>
<article-title>Clostridium and bacillus binary enterotoxins: Bad for the bowels, and eukaryotic being</article-title>
<source/>Toxins (Basel)
          <year>2014</year>
<volume>6</volume>
<fpage>2626</fpage>
<lpage>2656</lpage>
<pub-id pub-id-type="doi">10.3390/toxins6092626</pub-id>
<pub-id pub-id-type="pmid">25198129</pub-id>
</element-citation>
</ref>
<ref id="B29-ijms-20-04160">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gabriele</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sacco</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Altieri</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Neri</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Urbani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bravaccio</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Riccio</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Iovene</surname>
<given-names>M.R.</given-names>
</name>
<name>
<surname>Bombace</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>De Magistris</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Slow intestinal transit contributes to elevate urinary p-cresol level in Italian autistic children</article-title>
<source/>Autism. Res.
          <year>2016</year>
<volume>9</volume>
<fpage>752</fpage>
<lpage>759</lpage>
<pub-id pub-id-type="doi">10.1002/aur.1571</pub-id>
<pub-id pub-id-type="pmid">26437875</pub-id>
</element-citation>
</ref>
<ref id="B30-ijms-20-04160">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dalile</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Van Oudenhove</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Vervliet</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Verbeke</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>The role of short-chain fatty acids in microbiota-gut-brain communication</article-title>
<source/>Nat. Rev. Gastroenterol. Hepatol.
          <year>2019</year>
<comment>[Epub ahead of print]</comment>
<pub-id pub-id-type="doi">10.1038/s41575-019-0157-3</pub-id>
</element-citation>
</ref>
<ref id="B31-ijms-20-04160">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shultz</surname>
<given-names>S.R.</given-names>
</name>
<name>
<surname>Aziz</surname>
<given-names>N.A.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>MacFabe</surname>
<given-names>D.F.</given-names>
</name>
<name>
<surname>O’Brien</surname>
<given-names>T.J.</given-names>
</name>
</person-group>
<article-title>Intracerebroventricular injection of propionic acid, an enteric metabolite implicated in autism, induces social abnormalities that do not differ between seizure-prone (FAST) and seizure-resistant (SLOW) rats</article-title>
<source/>Behav. Brain Res.
          <year>2015</year>
<volume>278</volume>
<fpage>542</fpage>
<lpage>548</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbr.2014.10.050</pub-id>
<pub-id pub-id-type="pmid">25446754</pub-id>
</element-citation>
</ref>
<ref id="B32-ijms-20-04160">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macfabe</surname>
<given-names>D.F.</given-names>
</name>
</person-group>
<article-title>Short-chain fatty acid fermentation products of the gut microbiome: Implications in autism spectrum disorders</article-title>
<source/>Microb. Ecol. Health Dis.
          <year>2012</year>
<volume>23</volume>
<pub-id pub-id-type="doi">10.3402/mehd.v23i0.19260</pub-id>
</element-citation>
</ref>
<ref id="B33-ijms-20-04160">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Christophersen</surname>
<given-names>C.T.</given-names>
</name>
<name>
<surname>Sorich</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Gerber</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Angley</surname>
<given-names>M.T.</given-names>
</name>
<name>
<surname>Conlon</surname>
<given-names>M.A.</given-names>
</name>
</person-group>
<article-title>Elevated fecal short chain fatty acid and ammonia concentrations in children with autism spectrum disorder</article-title>
<source/>Dig. Dis. Sci.
          <year>2012</year>
<volume>57</volume>
<fpage>2096</fpage>
<lpage>2102</lpage>
<pub-id pub-id-type="doi">10.1007/s10620-012-2167-7</pub-id>
<pub-id pub-id-type="pmid">22535281</pub-id>
</element-citation>
</ref>
<ref id="B34-ijms-20-04160">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Ilhan</surname>
<given-names>Z.E.</given-names>
</name>
<name>
<surname>Isern</surname>
<given-names>N.G.</given-names>
</name>
<name>
<surname>Hoyt</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Howsmon</surname>
<given-names>D.P.</given-names>
</name>
<name>
<surname>Shaffer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lozupone</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Hahn</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Adams</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Krajmalnik-Brown</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Differences in fecal microbial metabolites and microbiota of children with autism spectrum disorders</article-title>
<source/>Anaerobe
          <year>2018</year>
<volume>49</volume>
<fpage>121</fpage>
<lpage>131</lpage>
<pub-id pub-id-type="doi">10.1016/j.anaerobe.2017.12.007</pub-id>
<pub-id pub-id-type="pmid">29274915</pub-id>
</element-citation>
</ref>
<ref id="B35-ijms-20-04160">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vicari</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pontillo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Armando</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Neurodevelopmental and psychiatric issues in Down’s syndrome: Assessment and intervention</article-title>
<source/>Psychiatr. Genet.
          <year>2013</year>
<volume>23</volume>
<fpage>95</fpage>
<lpage>107</lpage>
<pub-id pub-id-type="doi">10.1097/YPG.0b013e32835fe426</pub-id>
<pub-id pub-id-type="pmid">23492931</pub-id>
</element-citation>
</ref>
<ref id="B36-ijms-20-04160">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biagi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Candela</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Centanni</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Consolandi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rampelli</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Turroni</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Severgnini</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Peano</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ghezzo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Scurti</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gut microbiome in Down syndrome</article-title>
<source/>PLoS ONE
          <year>2014</year>
<volume>9</volume>
<elocation-id>e112023</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pone.0112023</pub-id>
<pub-id pub-id-type="pmid">25386941</pub-id>
</element-citation>
</ref>
<ref id="B37-ijms-20-04160">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amir</surname>
<given-names>R.E.</given-names>
</name>
<name>
<surname>Van den Veyver</surname>
<given-names>I.B.</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>C.Q.</given-names>
</name>
<name>
<surname>Francke</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Zoghbi</surname>
<given-names>H.Y.</given-names>
</name>
</person-group>
<article-title>Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2</article-title>
<source/>Nat. Genet.
          <year>1999</year>
<volume>23</volume>
<fpage>185</fpage>
<lpage>188</lpage>
<pub-id pub-id-type="doi">10.1038/13810</pub-id>
<pub-id pub-id-type="pmid">10508514</pub-id>
</element-citation>
</ref>
<ref id="B38-ijms-20-04160">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marschik</surname>
<given-names>P.B.</given-names>
</name>
<name>
<surname>Kaufmann</surname>
<given-names>W.E.</given-names>
</name>
<name>
<surname>Sigafoos</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wolin</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bartl-Pokorny</surname>
<given-names>K.D.</given-names>
</name>
<name>
<surname>Pini</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zappella</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tager-Flusberg</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Einspieler</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Changing the perspective on early development of Rett syndrome</article-title>
<source/>Res. Dev. Disabil.
          <year>2013</year>
<volume>34</volume>
<fpage>1236</fpage>
<lpage>1239</lpage>
<pub-id pub-id-type="doi">10.1016/j.ridd.2013.01.014</pub-id>
<pub-id pub-id-type="pmid">23400005</pub-id>
</element-citation>
</ref>
<ref id="B39-ijms-20-04160">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neul</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Kaufmann</surname>
<given-names>W.E.</given-names>
</name>
<name>
<surname>Glaze</surname>
<given-names>D.G.</given-names>
</name>
<name>
<surname>Christodoulou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Bahi-Buisson</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Leonard</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bailey</surname>
<given-names>M.E.S.</given-names>
</name>
<name>
<surname>Schanen</surname>
<given-names>N.C.</given-names>
</name>
<name>
<surname>Zappella</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rett syndrome: Revised diagnostic criteria and nomenclature</article-title>
<source/>Ann. Neurol.
          <year>2010</year>
<volume>68</volume>
<fpage>944</fpage>
<lpage>950</lpage>
<pub-id pub-id-type="doi">10.1002/ana.22124</pub-id>
<pub-id pub-id-type="pmid">21154482</pub-id>
</element-citation>
</ref>
<ref id="B40-ijms-20-04160">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bahi-Buisson</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Guellec</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Nabbout</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Guet</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nguyen</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Dulac</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Chiron</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Parental view of epilepsy in Rett Syndrome</article-title>
<source/>Brain Dev.
          <year>2008</year>
<volume>30</volume>
<fpage>126</fpage>
<lpage>130</lpage>
<pub-id pub-id-type="pmid">17707604</pub-id>
</element-citation>
</ref>
<ref id="B41-ijms-20-04160">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Byiers</surname>
<given-names>B.J.</given-names>
</name>
<name>
<surname>Tervo</surname>
<given-names>R.C.</given-names>
</name>
<name>
<surname>Feyma</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Symons</surname>
<given-names>F.J.</given-names>
</name>
</person-group>
<article-title>Seizures and pain uncertainty associated with parenting stress and Rett syndrome</article-title>
<source/>J. Child. Neurol.
          <year>2014</year>
<volume>29</volume>
<fpage>526</fpage>
<lpage>529</lpage>
<pub-id pub-id-type="doi">10.1177/0883073812470736</pub-id>
<pub-id pub-id-type="pmid">23307883</pub-id>
</element-citation>
</ref>
<ref id="B42-ijms-20-04160">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Motil</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Caeg</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Barrish</surname>
<given-names>J.O.</given-names>
</name>
<name>
<surname>Geerts</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lane</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Percy</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Annese</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>McNair</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Skinner</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H.S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gastrointestinal and nutritional problems occur frequently throughout life in girls and women with Rett syndrome</article-title>
<source/>J. Pediatr. Gastroenterol. Nutr.
          <year>2012</year>
<volume>55</volume>
<fpage>292</fpage>
<lpage>298</lpage>
<pub-id pub-id-type="doi">10.1097/MPG.0b013e31824b6159</pub-id>
<pub-id pub-id-type="pmid">22331013</pub-id>
</element-citation>
</ref>
<ref id="B43-ijms-20-04160">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Freilinger</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Böhm</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lanator</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Vergesslich-Rothschild</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>W.D.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Baikie</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ravikumara</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Downs</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prevalence, clinical investigation, and management of gallbladder disease in Rett syndrome</article-title>
<source/>Dev. Med. Child. Neurol.
          <year>2014</year>
<volume>56</volume>
<fpage>756</fpage>
<lpage>762</lpage>
<pub-id pub-id-type="doi">10.1111/dmcn.12358</pub-id>
<pub-id pub-id-type="pmid">24528171</pub-id>
</element-citation>
</ref>
<ref id="B44-ijms-20-04160">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baikie</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ravikumara</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Downs</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Naseem</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Percy</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lane</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ellaway</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bathgate</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Gastrointestinal dysmotility in Rett syndrome</article-title>
<source/>J. Pediatr. Gastroenterol. Nutr.
          <year>2014</year>
<volume>58</volume>
<fpage>237</fpage>
<lpage>244</lpage>
<pub-id pub-id-type="doi">10.1097/MPG.0000000000000200</pub-id>
<pub-id pub-id-type="pmid">24121144</pub-id>
</element-citation>
</ref>
<ref id="B45-ijms-20-04160">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>MacKay</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Leonard</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Downs</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Respiratory morbidity in Rett syndrome: An observational study</article-title>
<source/>Dev. Med. Child Neurol.
          <year>2018</year>
<volume>60</volume>
<fpage>951</fpage>
<lpage>957</lpage>
<pub-id pub-id-type="doi">10.1111/dmcn.13726</pub-id>
<pub-id pub-id-type="pmid">29536504</pub-id>
</element-citation>
</ref>
<ref id="B46-ijms-20-04160">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strati</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Cavalieri</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Albanese</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>de Felice</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Donati</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Hayek</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jousson</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Leoncini</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pindo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Renzi</surname>
<given-names>D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Altered gut microbiota in Rett syndrome</article-title>
<source/>Microbiome
          <year>2016</year>
<volume>4</volume>
<fpage>41</fpage>
<pub-id pub-id-type="doi">10.1186/s40168-016-0185-y</pub-id>
<pub-id pub-id-type="pmid">27473171</pub-id>
</element-citation>
</ref>
<ref id="B47-ijms-20-04160">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borghi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Borgo</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Severgnini</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Savini</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Casiraghi</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Vignoli</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Rett syndrome: A focus on gut microbiota</article-title>
<source/>Int J. Mol. Sci.
          <year>2017</year>
<volume>18</volume>
<elocation-id>344</elocation-id>
<pub-id pub-id-type="doi">10.3390/ijms18020344</pub-id>
</element-citation>
</ref>
<ref id="B48-ijms-20-04160">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mosca</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Leclerc</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hugot</surname>
<given-names>J.P.</given-names>
</name>
</person-group>
<article-title>Gut microbiota diversity and human diseases: Should we reintroduce key predators in our ecosystem?</article-title>
<source/>Front. Microbiol.
          <year>2016</year>
<volume>7</volume>
<fpage>455</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2016.00455</pub-id>
<pub-id pub-id-type="pmid">27065999</pub-id>
</element-citation>
</ref>
<ref id="B49-ijms-20-04160">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turroni</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ribbera</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Foroni</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>van Sinderen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ventura</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Human gut microbiota and bifidobacteria: From composition to functionality</article-title>
<source/>Antonie. Van Leeuwenhoek
          <year>2008</year>
<volume>94</volume>
<fpage>35</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="doi">10.1007/s10482-008-9232-4</pub-id>
<pub-id pub-id-type="pmid">18338233</pub-id>
</element-citation>
</ref>
<ref id="B50-ijms-20-04160">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riva</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Borgo</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Lassandro</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Verduci</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Morace</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Borghi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Berry</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Pediatric obesity is associated with an altered gut microbiota and discordant shifts in Firmicutes populations</article-title>
<source/>Env. Microbiol.
          <year>2017</year>
<volume>9</volume>
<fpage>95</fpage>
<lpage>105</lpage>
<pub-id pub-id-type="doi">10.1111/1462-2920.13463</pub-id>
</element-citation>
</ref>
<ref id="B51-ijms-20-04160">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandes</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Rahat-Rozenbloom</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wolever</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Comelli</surname>
<given-names>E.M.</given-names>
</name>
</person-group>
<article-title>Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans</article-title>
<source/>Nutr. Diabetes
          <year>2014</year>
<volume>4</volume>
<fpage>e121</fpage>
<pub-id pub-id-type="doi">10.1038/nutd.2014.23</pub-id>
<pub-id pub-id-type="pmid">24979150</pub-id>
</element-citation>
</ref>
<ref id="B52-ijms-20-04160">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Indiani</surname>
<given-names>C.M.D.S.P.</given-names>
</name>
<name>
<surname>Rizzardi</surname>
<given-names>K.F.</given-names>
</name>
<name>
<surname>Castelo</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Ferraz</surname>
<given-names>L.F.C.</given-names>
</name>
<name>
<surname>Darrieux</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Parisotto</surname>
<given-names>T.M.</given-names>
</name>
</person-group>
<article-title>Childhood Obesity and Firmicutes/Bacteroidetes Ratio in the Gut Microbiota: A Systematic Review</article-title>
<source/>Child. Obes.
          <year>2018</year>
<volume>14</volume>
<fpage>501</fpage>
<lpage>509</lpage>
<pub-id pub-id-type="doi">10.1089/chi.2018.0040</pub-id>
<pub-id pub-id-type="pmid">30183336</pub-id>
</element-citation>
</ref>
<ref id="B53-ijms-20-04160">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nyangale</surname>
<given-names>E.P.</given-names>
</name>
<name>
<surname>Mottram</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>G.R.</given-names>
</name>
</person-group>
<article-title>Gut microbial activity, implications for health and disease: The potential role of metabolite analysis</article-title>
<source/>J. Proteome Res.
          <year>2012</year>
<volume>11</volume>
<fpage>5573</fpage>
<lpage>5585</lpage>
<pub-id pub-id-type="doi">10.1021/pr300637d</pub-id>
<pub-id pub-id-type="pmid">23116228</pub-id>
</element-citation>
</ref>
<ref id="B54-ijms-20-04160">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zoghbi</surname>
<given-names>H.Y.</given-names>
</name>
</person-group>
<article-title>Mouse models as a tool for discovering new neurological diseases</article-title>
<source/>Neurobiol. Learn. Mem.
          <year>2018</year>
<pub-id pub-id-type="doi">10.1016/j.nlm.2018.07.006</pub-id>
</element-citation>
</ref>
<ref id="B55-ijms-20-04160">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wither</surname>
<given-names>R.G.</given-names>
</name>
<name>
<surname>Colic</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bardakjian</surname>
<given-names>B.L.</given-names>
</name>
<name>
<surname>Snead</surname>
<given-names>O.C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Eubanks</surname>
<given-names>J.H.</given-names>
</name>
</person-group>
<article-title>Electrographic and Pharmacological Characterization of a Progressive Epilepsy Phenotype in Female MeCP2-Deficient Mice</article-title>
<source/>Epilepsy Res.
          <year>2018</year>
<volume>140</volume>
<fpage>177</fpage>
<lpage>183</lpage>
<pub-id pub-id-type="doi">10.1016/j.eplepsyres.2018.01.015</pub-id>
<pub-id pub-id-type="pmid">29414525</pub-id>
</element-citation>
</ref>
<ref id="B56-ijms-20-04160">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McLeod</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ganley</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Selfridge</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bird</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cobb</surname>
<given-names>S.R.</given-names>
</name>
</person-group>
<article-title>Reduced Seizure Threshold and Altered Network Oscillatory Properties in a Mouse Model of Rett Syndrome</article-title>
<source/>Neuroscience
          <year>2013</year>
<volume>231</volume>
<fpage>195</fpage>
<lpage>205</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2012.11.058</pub-id>
<pub-id pub-id-type="pmid">23238573</pub-id>
</element-citation>
</ref>
<ref id="B57-ijms-20-04160">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Millar-Büchner</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Philp</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Gutierrez</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Villanueva</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kerr</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Flores</surname>
<given-names>C.A.</given-names>
</name>
</person-group>
<article-title>Severe changes in colon epithelium in the Mecp2-null mouse model of Rett syndrome</article-title>
<source/>Mol. Cell Pediatr.
          <year>2016</year>
<volume>3</volume>
<fpage>37</fpage>
<pub-id pub-id-type="doi">10.1186/s40348-016-0065-3</pub-id>
<pub-id pub-id-type="pmid">27868160</pub-id>
</element-citation>
</ref>
<ref id="B58-ijms-20-04160">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tuchman</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rapin</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Epilepsy in autism</article-title>
<source/>Lancet Neurol.
          <year>2002</year>
<volume>1</volume>
<fpage>352</fpage>
<lpage>358</lpage>
<pub-id pub-id-type="doi">10.1016/S1474-4422(02)00160-6</pub-id>
<pub-id pub-id-type="pmid">12849396</pub-id>
</element-citation>
</ref>
<ref id="B59-ijms-20-04160">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nissenkorn</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Levy-Drummer</surname>
<given-names>R.S.</given-names>
</name>
<name>
<surname>Bondi</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Renieri</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Villard</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Mari</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mencarelli</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Lo Rizzo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Meloni</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Pineda</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Epilepsy in Rett syndrome--lessons from the Rett networked database</article-title>
<source/>Epilepsia
          <year>2015</year>
<volume>56</volume>
<fpage>569</fpage>
<lpage>576</lpage>
<pub-id pub-id-type="doi">10.1111/epi.12941</pub-id>
<pub-id pub-id-type="pmid">25789914</pub-id>
</element-citation>
</ref>
<ref id="B60-ijms-20-04160">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vignoli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Savini</surname>
<given-names>M.N.</given-names>
</name>
<name>
<surname>Nowbut</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Peron</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>La Briola</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Canevini</surname>
<given-names>M.P.</given-names>
</name>
</person-group>
<article-title>Effectiveness and tolerability of antiepileptic drugs in 104 girls with Rett syndrome</article-title>
<source/>Epilepsy Behav.
          <year>2017</year>
<volume>66</volume>
<fpage>27</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="doi">10.1016/j.yebeh.2016.10.006</pub-id>
<pub-id pub-id-type="pmid">27988477</pub-id>
</element-citation>
</ref>
<ref id="B61-ijms-20-04160">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tarquinio</surname>
<given-names>D.C.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Berg</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kaufmann</surname>
<given-names>W.E.</given-names>
</name>
<name>
<surname>Lane</surname>
<given-names>J.B.</given-names>
</name>
<name>
<surname>Skinner</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Motil</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Neul</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Percy</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Glaze</surname>
<given-names>D.G.</given-names>
</name>
</person-group>
<article-title>Longitudinal course of epilepsy in Rett syndrome and related disorders</article-title>
<source/>Brain
          <year>2017</year>
<volume>140</volume>
<fpage>306</fpage>
<lpage>318</lpage>
<pub-id pub-id-type="doi">10.1093/brain/aww302</pub-id>
<pub-id pub-id-type="pmid">28007990</pub-id>
</element-citation>
</ref>
<ref id="B62-ijms-20-04160">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>B.T.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>C.Y.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>G.Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F.M.</given-names>
</name>
</person-group>
<article-title>Fecal microbiota transplantation cured epilepsy in a case with Crohn’s disease: The first report</article-title>
<source/>World J. Gastroenterol.
          <year>2017</year>
<volume>23</volume>
<fpage>3565</fpage>
<lpage>3568</lpage>
<pub-id pub-id-type="doi">10.3748/wjg.v23.i19.3565</pub-id>
<pub-id pub-id-type="pmid">28596693</pub-id>
</element-citation>
</ref>
<ref id="B63-ijms-20-04160">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Altered composition of the gut microbiome in patients with drug-resistant epilepsy</article-title>
<source/>Epilepsy Res.
          <year>2018</year>
<volume>147</volume>
<fpage>102</fpage>
<lpage>107</lpage>
<pub-id pub-id-type="doi">10.1016/j.eplepsyres.2018.09.013</pub-id>
<pub-id pub-id-type="pmid">30291996</pub-id>
</element-citation>
</ref>
<ref id="B64-ijms-20-04160">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gómez-Eguílaz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ramón-Trapero</surname>
<given-names>J.L.</given-names>
</name>
<name>
<surname>Pérez-Martínez</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Blanco</surname>
<given-names>J.R.</given-names>
</name>
</person-group>
<article-title>The beneficial effect of probiotics as a supplementary treatment in drug-resistant epilepsy: A pilot study</article-title>
<source/>Benef. Microbes.
          <year>2018</year>
<volume>9</volume>
<fpage>875</fpage>
<lpage>881</lpage>
<pub-id pub-id-type="doi">10.3920/BM2018.0018</pub-id>
<pub-id pub-id-type="pmid">30198325</pub-id>
</element-citation>
</ref>
<ref id="B65-ijms-20-04160">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maier</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pruteanu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kuhn</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zeller</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Telzerow</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>E.E.</given-names>
</name>
<name>
<surname>Brochado</surname>
<given-names>A.R.</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>K.C.</given-names>
</name>
<name>
<surname>Dose</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Extensive impact of non-antibiotic drugs on human gut bacteria</article-title>
<source/>Nature
          <year>2018</year>
<volume>555</volume>
<fpage>623</fpage>
<lpage>628</lpage>
<pub-id pub-id-type="doi">10.1038/nature25979</pub-id>
<pub-id pub-id-type="pmid">29555994</pub-id>
</element-citation>
</ref>
<ref id="B66-ijms-20-04160">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tagliabue</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ferraris</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Uggeri</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Trentani</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bertoli</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>de Giorgis</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Veggiotti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Elli</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Short-term impact of a classical ketogenic diet on gut microbiota in GLUT1 Deficiency Syndrome: A 3-month prospective observational study</article-title>
<source/>Clin. Nutr. ESPEN
          <year>2017</year>
<volume>17</volume>
<fpage>33</fpage>
<lpage>37</lpage>
<pub-id pub-id-type="doi">10.1016/j.clnesp.2016.11.003</pub-id>
<pub-id pub-id-type="pmid">28361745</pub-id>
</element-citation>
</ref>
<ref id="B67-ijms-20-04160">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y.R.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>L.Z.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>S.T.</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>H.Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G.X.</given-names>
</name>
</person-group>
<article-title>Isolation of Desulfovibrio spp. from human gut microbiota using a next-generation sequencing directed culture method</article-title>
<source/>Lett. Appl. Microbiol.
          <year>2019</year>
<volume>68</volume>
<fpage>553</fpage>
<lpage>561</lpage>
<pub-id pub-id-type="doi">10.1111/lam.13149</pub-id>
<pub-id pub-id-type="pmid">30835854</pub-id>
</element-citation>
</ref>
<ref id="B68-ijms-20-04160">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Ketogenic diet poses a significant effect on imbalanced gut microbiota in infants with refractory epilepsy</article-title>
<source/>World J. Gastroenterol.
          <year>2017</year>
<volume>23</volume>
<fpage>6164</fpage>
<lpage>6171</lpage>
<pub-id pub-id-type="doi">10.3748/wjg.v23.i33.6164</pub-id>
<pub-id pub-id-type="pmid">28970732</pub-id>
</element-citation>
</ref>
<ref id="B69-ijms-20-04160">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Altered gut microbiome composition in children with refractory epilepsy after ketogenic diet</article-title>
<source/>Epilepsy Res.
          <year>2018</year>
<volume>145</volume>
<fpage>163</fpage>
<lpage>168</lpage>
<pub-id pub-id-type="doi">10.1016/j.eplepsyres.2018.06.015</pub-id>
<pub-id pub-id-type="pmid">30007242</pub-id>
</element-citation>
</ref>
<ref id="B70-ijms-20-04160">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lindefeldt</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Eng</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Darban</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bjerkner</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zetterström</surname>
<given-names>C.K.</given-names>
</name>
<name>
<surname>Allander</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Andersson</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Borenstein</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Dahlin</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Prast-Nielsen</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>The ketogenic diet influences taxonomic and functional composition of the gut microbiota in children with severe epilepsy</article-title>
<source/>NPJ Biofilms Microbiomes
          <year>2019</year>
<volume>5</volume>
<fpage>5</fpage>
<pub-id pub-id-type="doi">10.1038/s41522-018-0073-2</pub-id>
<pub-id pub-id-type="pmid">30701077</pub-id>
</element-citation>
</ref>
<ref id="B71-ijms-20-04160">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dolce</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ben-Zeev</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Naidu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kossoff</surname>
<given-names>E.H.</given-names>
</name>
</person-group>
<article-title>Rett syndrome and epilepsy: An update for child neurologists</article-title>
<source/>Pediatr. Neurol.
          <year>2013</year>
<volume>48</volume>
<fpage>337</fpage>
<lpage>435</lpage>
<pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2012.11.001</pub-id>
<pub-id pub-id-type="pmid">23583050</pub-id>
</element-citation>
</ref>
<ref id="B72-ijms-20-04160">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Olson</surname>
<given-names>H.E.</given-names>
</name>
<name>
<surname>Bergin</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Downs</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Leonard</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Use of the ketogenic diet to manage refractory epilepsy in CDKL5 disorder: Experience of &gt;100 patients</article-title>
<source/>Epilepsia
          <year>2017</year>
<volume>58</volume>
<fpage>1415</fpage>
<lpage>1422</lpage>
<pub-id pub-id-type="doi">10.1111/epi.13813</pub-id>
<pub-id pub-id-type="pmid">28605011</pub-id>
</element-citation>
</ref>
<ref id="B73-ijms-20-04160">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L.J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C.Y.</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Chou</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Yeh</surname>
<given-names>Y.M.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S.Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>L.H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.C.</given-names>
</name>
</person-group>
<article-title>Gut microbiota and dietary patterns in children with attention-deficit/hyperactivity disorder</article-title>
<source/>Eur. Child Adolesc. Psychiatry
          <year>2019</year>
<comment>[Epub ahead of print]</comment>
<pub-id pub-id-type="doi">10.1007/s00787-019-01352-2</pub-id>
</element-citation>
</ref>
<ref id="B74-ijms-20-04160">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bäuerl</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Collado</surname>
<given-names>M.C.</given-names>
</name>
<name>
<surname>Diaz Cuevas</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Viña</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Pérez Martínez</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Shifts in gut microbiota composition in an APP/PSS1 transgenic mouse model of Alzheimer’s disease during lifespan</article-title>
<source/>Lett. Appl. Microbiol.
          <year>2018</year>
<volume>66</volume>
<fpage>464</fpage>
<lpage>471</lpage>
<pub-id pub-id-type="doi">10.1111/lam.12882</pub-id>
<pub-id pub-id-type="pmid">29575030</pub-id>
</element-citation>
</ref>
<ref id="B75-ijms-20-04160">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coretti</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cristiano</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Florio</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Scala</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lama</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Keller</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cuomo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Russo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Pero</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Paciello</surname>
<given-names>O.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sex-related alterations of gut microbiota composition in the BTBR mouse model of autism spectrum disorder</article-title>
<source/>Sci. Rep.
          <year>2017</year>
<volume>7</volume>
<fpage>45356</fpage>
<pub-id pub-id-type="doi">10.1038/srep45356</pub-id>
<pub-id pub-id-type="pmid">28349974</pub-id>
</element-citation>
</ref>
<ref id="B76-ijms-20-04160">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hiippala</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kainulainen</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Kalliomäki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Arkkila</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Satokari</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Mucosal prevalence and interactions with the epithelium indicate commensalism of Sutterella spp.</article-title>
<source/>Front. Microbiol.
          <year>2016</year>
<volume>7</volume>
<fpage>1706</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2016.01706</pub-id>
<pub-id pub-id-type="pmid">27833600</pub-id>
</element-citation>
</ref>
<ref id="B77-ijms-20-04160">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nowak</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Libudzisz</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Influence of phenol, p-cresol and indole on growth and survival of intestinal lactic acid bacteria</article-title>
<source/>Anaerobe
          <year>2006</year>
<volume>12</volume>
<fpage>80</fpage>
<lpage>84</lpage>
<pub-id pub-id-type="doi">10.1016/j.anaerobe.2005.10.003</pub-id>
<pub-id pub-id-type="pmid">16701619</pub-id>
</element-citation>
</ref>
<ref id="B78-ijms-20-04160">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barrett</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>R.P.</given-names>
</name>
<name>
<surname>O’Toole</surname>
<given-names>P.W.</given-names>
</name>
<name>
<surname>Fitzgerald</surname>
<given-names>G.F.</given-names>
</name>
<name>
<surname>Stanton</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>γ-Aminobutyric acid production by culturable bacteria from the human intestine</article-title>
<source/>J. Appl. Microbiol.
          <year>2012</year>
<volume>113</volume>
<fpage>411</fpage>
<lpage>417</lpage>
<pub-id pub-id-type="doi">10.1111/j.1365-2672.2012.05344.x</pub-id>
<pub-id pub-id-type="pmid">22612585</pub-id>
</element-citation>
</ref>
<ref id="B79-ijms-20-04160">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pizzarelli</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Cherubini</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Alterations of GABAergic signaling in autism spectrum disorders</article-title>
<source/>Neural. Plast.
          <year>2011</year>
<volume>2011</volume>
<fpage>297153</fpage>
<pub-id pub-id-type="doi">10.1155/2011/297153</pub-id>
<pub-id pub-id-type="pmid">21766041</pub-id>
</element-citation>
</ref>
<ref id="B80-ijms-20-04160">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sapey-Triomphe</surname>
<given-names>L.A.</given-names>
</name>
<name>
<surname>Lamberton</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Sonié</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mattout</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Schmitz</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Tactile hypersensitivity and GABA concentration in the sensorimotor cortex of adults with autism</article-title>
<source/>Autism. Res.
          <year>2019</year>
<volume>12</volume>
<fpage>562</fpage>
<lpage>575</lpage>
<pub-id pub-id-type="doi">10.1002/aur.2073</pub-id>
<pub-id pub-id-type="pmid">30632707</pub-id>
</element-citation>
</ref>
<ref id="B81-ijms-20-04160">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Treiman</surname>
<given-names>D.M.</given-names>
</name>
</person-group>
<article-title>GABAergic mechanisms in epilepsy</article-title>
<source/>Epilepsia
          <year>2001</year>
<volume>42</volume>
<fpage>8</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1046/j.1528-1157.2001.042suppl.3008.x</pub-id>
<pub-id pub-id-type="pmid">11520315</pub-id>
</element-citation>
</ref>
<ref id="B82-ijms-20-04160">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Probiotic Bifidobacterium animalis subsp. lactis Bi-07 alleviates bacterial translocation and ameliorates microinflammation in experimental uraemia</article-title>
<source/>Nephrology
          <year>2014</year>
<volume>19</volume>
<fpage>500</fpage>
<lpage>506</lpage>
<pub-id pub-id-type="doi">10.1111/nep.12272</pub-id>
<pub-id pub-id-type="pmid">24787732</pub-id>
</element-citation>
</ref>
<ref id="B83-ijms-20-04160">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pintaudi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Veneselli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Voci</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Vignoli</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Castiglione</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Calevo</surname>
<given-names>M.G.</given-names>
</name>
<name>
<surname>Grasselli</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Ragazzoni</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cogliati</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Calzari</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Blood oxidative stress and metallothionein expression in Rett syndrome: Probing for markers</article-title>
<source/>World J. Biol. Psychiatry
          <year>2016</year>
<volume>17</volume>
<fpage>198</fpage>
<lpage>209</lpage>
<pub-id pub-id-type="doi">10.3109/15622975.2015.1077990</pub-id>
<pub-id pub-id-type="pmid">26469135</pub-id>
</element-citation>
</ref>
<ref id="B84-ijms-20-04160">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vezzani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Balosso</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ravizza</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy</article-title>
<source/>Nat. Rev. Neurol.
          <year>2019</year>
<volume>15</volume>
<fpage>459</fpage>
<lpage>472</lpage>
<pub-id pub-id-type="doi">10.1038/s41582-019-0217-x</pub-id>
<pub-id pub-id-type="pmid">31263255</pub-id>
</element-citation>
</ref>
<ref id="B85-ijms-20-04160">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Medel-Matus</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dorfman</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sankar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mazarati</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Facilitation of kindling epileptogenesis by chronic stress may be mediated by intestinal microbiome</article-title>
<source/>Epilepsia Open.
          <year>2018</year>
<volume>3</volume>
<fpage>290</fpage>
<lpage>294</lpage>
<pub-id pub-id-type="doi">10.1002/epi4.12114</pub-id>
<pub-id pub-id-type="pmid">29881810</pub-id>
</element-citation>
</ref>
<ref id="B86-ijms-20-04160">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tognini</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Gut Microbiota: A Potential Regulator of Neurodevelopment</article-title>
<source/>Front. Cell Neurosci
          <year>2017</year>
<volume>11</volume>
<fpage>25</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2017.00025</pub-id>
<pub-id pub-id-type="pmid">28223922</pub-id>
</element-citation>
</ref>
<ref id="B87-ijms-20-04160">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hotamisligil</surname>
<given-names>G.S.</given-names>
</name>
</person-group>
<article-title>Inflammation and metabolic disorders</article-title>
<source/>Nature
          <year>2006</year>
<volume>444</volume>
<fpage>860</fpage>
<lpage>867</lpage>
<pub-id pub-id-type="doi">10.1038/nature05485</pub-id>
<pub-id pub-id-type="pmid">17167474</pub-id>
</element-citation>
</ref>
<ref id="B88-ijms-20-04160">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaakoush</surname>
<given-names>N.O.</given-names>
</name>
</person-group>
<article-title>Insights into the Role of Erysipelotrichaceae in the Human Host</article-title>
<source/>Front. Cell Infect. Microbiol.
          <year>2015</year>
<volume>5</volume>
<fpage>84</fpage>
<pub-id pub-id-type="doi">10.3389/fcimb.2015.00084</pub-id>
<pub-id pub-id-type="pmid">26636046</pub-id>
</element-citation>
</ref>
<ref id="B89-ijms-20-04160">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rios-Covian</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Salazar</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Gueimonde</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>de Los Reyes-Gavilan</surname>
<given-names>C.G.</given-names>
</name>
</person-group>
<article-title>Shaping the Metabolism of Intestinal Bacteroides Population through Diet to Improve Human Health</article-title>
<source/>Front. Microbiol.
          <year>2017</year>
<volume>8</volume>
<fpage>376</fpage>
<pub-id pub-id-type="doi">10.3389/fmicb.2017.00376</pub-id>
<pub-id pub-id-type="pmid">28326076</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="ijms-20-04160-f001" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>Venn diagram presenting the shared clinical and microbial features between Rett Syndrome, autism spectrum disorder, and down syndrome.</p>
</caption>
<graphic xlink:href="ijms-20-04160-g001"></graphic>
</fig>
<fig id="ijms-20-04160-f002" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<p>Microbial modulation in neurodevelopmental disorders. Effects driven directly or indirectly by gut microbes, found to be increased in NDs and their products. (<bold>A</bold>) Clostridia are spore-forming, toxigenic bacteria, with proteolytic ability [<xref ref-type="bibr" rid="B53-ijms-20-04160">53</xref>]; digestion of aromatic amino acids results in phenol, p-cresol, and indole production. High indole concentrations can suppress bifidobacteria and lactobacilli growth [<xref ref-type="bibr" rid="B77-ijms-20-04160">77</xref>]. Lactic bacteria are known to endogenously produce gamma-aminobutyric acid (GABA) [<xref ref-type="bibr" rid="B78-ijms-20-04160">78</xref>]. GABA decrease has been reported as an underlying mechanism for stereotypies occurrence [<xref ref-type="bibr" rid="B79-ijms-20-04160">79</xref>], ASD hypersensitivity [<xref ref-type="bibr" rid="B80-ijms-20-04160">80</xref>], and epilepsy [<xref ref-type="bibr" rid="B81-ijms-20-04160">81</xref>]. (<bold>B</bold>) <italic>Enterobacteriaceae</italic> [<xref ref-type="bibr" rid="B87-ijms-20-04160">87</xref>], <italic>Sutturella</italic> spp. [<xref ref-type="bibr" rid="B76-ijms-20-04160">76</xref>], and <italic>Erysipelotrichaceae</italic> [<xref ref-type="bibr" rid="B88-ijms-20-04160">88</xref>] have been reported to exert a pro-inflammatory effect, which can alter gastrointestinal homeostasis and alter the gastrointestinal (GI) barrier permeability. (<bold>C</bold>) <italic>Bacteroides</italic> are nutritionally versatile bacteria, with both saccharolytic and proteolytic activity [<xref ref-type="bibr" rid="B53-ijms-20-04160">53</xref>]; a rich-protein diet promotes the production of branched-chain fatty acids (BCFAs) and propionate [<xref ref-type="bibr" rid="B89-ijms-20-04160">89</xref>]. High propionate concentrations have demonstrated to exert behavioral and social impairment in animal models [<xref ref-type="bibr" rid="B31-ijms-20-04160">31</xref>].</p>
</caption>
<graphic xlink:href="ijms-20-04160-g002"></graphic>
</fig>
<table-wrap id="ijms-20-04160-t001" orientation="portrait" position="float">
<object-id pub-id-type="pii">ijms-20-04160-t001_Table 1</object-id>
<label>Table 1</label>
<caption>
<p>Characteristics of gut microbiota studies in Rett syndrome (RTT).</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin;background:#E5E5E5" valign="middle">Reference</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin;background:#E5E5E5" valign="middle">Cohort</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin;background:#E5E5E5" valign="middle">Mean Age (years)</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin;background:#E5E5E5" valign="middle">Age Range</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin;background:#E5E5E5" valign="middle">GI<sup>a</sup> Symptoms (%)</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin;background:#E5E5E5" valign="middle">Methods</th>
<th align="center" colspan="1" rowspan="1" style="border-top:solid thin;border-bottom:solid thin;background:#E5E5E5" valign="middle">Results (RTT vs HC<sup>b</sup>)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" colspan="1" rowspan="3" valign="middle">Strati et al., 2017</td>
<td align="center" colspan="1" rowspan="1" valign="middle">50 RTT</td>
<td align="center" colspan="1" rowspan="1" valign="middle">12.6 ± 7.3</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.5–32</td>
<td align="center" colspan="1" rowspan="3" valign="middle">68%</td>
<td align="center" colspan="1" rowspan="3" valign="top"><underline>16S rRNA sequencing</underline>: <break></break>V3-V5 hypervariable regions; <break></break>454 pyrosequencing platform; Greengenes<break></break>Version 13.05 </td>
<td align="center" colspan="1" rowspan="3" valign="middle">↓ α-diversity<sup>c</sup><break></break>β- diversity<sup>d</sup> (<italic>p</italic> ≤ 0.003)<break></break><break></break>↑ Actinobacteria<break></break>↓ Bacteroidetes<break></break>↑ <italic>Bifidobacterium</italic> spp.<break></break>↑ <italic>Clostridium</italic> spp.<italic>, Enterococcus,</italic><break></break><italic>Erysipelotrichaceae incertae sedis, Escherichia/Shigella</italic> and <italic>Megasphaera</italic><break></break><break></break>↑ <italic>Candida</italic> spp.</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">(MECp2; n = 48)<break></break>(CDKL5; n=2)</td>
<td align="center" colspan="1" rowspan="1" valign="middle"></td>
<td align="center" colspan="1" rowspan="1" valign="middle"></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">29 HC<sup>b</sup></td>
<td align="center" colspan="1" rowspan="1" valign="middle">17.4 ± 9.6</td>
<td align="center" colspan="1" rowspan="1" valign="middle">1.5–32</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><underline>SCFA<sup>e</sup> quantification:</underline><break></break>Gas chromatography</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">↑ Propionate, <italic>iso</italic>-butyrate and <italic>iso-</italic>valerate (in feces)</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="3" valign="middle">Borghi et al., 2017</td>
<td align="center" colspan="1" rowspan="1" valign="middle">8 RTT</td>
<td align="center" colspan="1" rowspan="1" valign="middle">23.0 ± 8.7</td>
<td align="center" colspan="1" rowspan="1" valign="middle">9–39</td>
<td align="center" colspan="1" rowspan="3" valign="middle">100%</td>
<td align="center" colspan="1" rowspan="3" valign="top"><underline>16S rRNA sequencing</underline>: <break></break>V3-V4 hypervariable regions; MiSeq Illumina platform; Greengenes<break></break>Version 13.8 </td>
<td align="center" colspan="1" rowspan="3" valign="middle">↓ α-diversity<sup>c</sup> (a severity-related decrease)<break></break>β- diversity<sup>d</sup> (<italic>p</italic> ≤ 0.05, only severe RTT vs HC)<break></break><break></break>↑ <italic>Bacteroides</italic> spp.<break></break>↑ <italic>Clostridium</italic> spp.<break></break>↑ <italic>Sutterella</italic> spp.<break></break>↓ <italic>Faecalibacterium</italic> spp.<break></break>↓ <italic>Roseburia</italic> spp.<break></break>↓ <italic>Prevotella</italic> spp.<break></break><break></break>↑ <italic>Enterobacteriacae, B</italic><italic>acteroidaceae</italic>
<break></break>and <italic>Erysipelotrichaceae</italic> (severity-related)</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">(MECp2; n = 8)</td>
<td align="center" colspan="1" rowspan="1" valign="middle"></td>
<td align="center" colspan="1" rowspan="1" valign="middle"></td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" valign="middle">10 HC<sup>b</sup></td>
<td align="center" colspan="1" rowspan="1" valign="middle">24.5 ± 6.6</td>
<td align="center" colspan="1" rowspan="1" valign="middle">18–41</td>
</tr>
<tr>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">
</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle"><underline>SCFA<sup>e</sup> quantification:</underline><break></break>Gas chromatography</td>
<td align="center" colspan="1" rowspan="1" style="border-bottom:solid thin" valign="middle">↑ Propionate, butyrate, <italic>iso</italic>-butyrate and <italic>iso-</italic>valerate (in feces)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p><sup>a</sup>GI, Gastrointestinal tract; <sup>b</sup>HC, healthy controls; <sup>c</sup>α-diversity, the diversity in the bacterial composition within each sample; <sup>d</sup>β- diversity, the diversity between sample groups; <sup>e</sup>SCFA, short-chain fatty acids.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>